story of the week
Efficacy and Safety of Dapagliflozin According to Sex in Patients With Heart Failure Across the Range of LVEF
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Circulation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Sex Differences in Characteristics, Outcomes and Treatment Response with Dapagliflozin across the Range of Ejection Fraction in Patients with Heart Failure: Insights from DAPA-HF and DELIVER
Circulation 2022 Nov 07;[EPub Ahead of Print], X Wang, M Vaduganathan, BL Claggett, SM Hegde, M Pabon, IJ Kulac, O Vardeny, E O'Meara, S Zieroth, T Katova, MM McGrath, AC Pouleur, PS Jhund, AS Desai, SE Inzucchi, MN Kosiborod, RA de Boer, L Køber, MS Sabatine, FA Martinez, P Ponikowski, SJ Shah, AF Hernandez, AM Langkilde, JJV McMurray, SD Solomon, CSP LamFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.